|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/04 | |
| A61K 31/55 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2046386 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 07764967.1 |
| Europos patento paraiškos padavimo data | 2007-06-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2009-04-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-07-23 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2007/005806 |
| Data | 2007-06-29 |
| (87) | Numeris | WO 2008/000513 |
| Data | 2008-01-03 |
| (30) | Numeris | Data | Šalis |
| 06013655 | 2006-06-30 | EP | |
| 06021469 | 2006-10-12 | EP | |
| 06021470 | 2006-10-12 | EP | |
| 06024241 | 2006-11-22 | EP |
| (72) |
HEERS, Cara, DE
STÖHR, Thomas, DE
BEYREUTHER, Bettina, DE
|
| (73) |
UCB Pharma GmbH,
Alfred-Nobel-Strasse 10, 40789 Monheim,
DE
|
| (54) | PEPTIDE COMPOUNDS FOR THE TREATMENT OF SKELETAL MUSCLE DISORDERS ASSOCIATED WITH ION CHANNEL DYSFUNCTION |
| PEPTIDE COMPOUNDS FOR THE TREATMENT OF SKELETAL MUSCLE DISORDERS ASSOCIATED WITH ION CHANNEL DYSFUNCTION |